Ketone markers in urine, blood, and breath have held a longstanding fascination for medical professionals and individuals seeking wellness optimization. These markers are vital indicators of the body’s metabolic state, shedding light on using fats as an energy source, making them invaluable for conditions like diabetes and weight management. Despite their significance, traditional methods of ketone measurement have been plagued by inherent limitations. Urine tests frequently introduce undesirable delays, where results may not be promptly available. Blood tests are invasive and often associated with pain and discomfort. In addition, the messiness associated with handling bodily fluids in blood and urine tests poses practical challenges, especially in home-based monitoring scenarios.
Moreover, most breath tests on the market are susceptible to interference from other gases. These conventional breath meters often struggle to maintain precision in environments with varying gas compositions, potentially leading to inaccurate measurements. This drawback has limited their reliability and hindered their widespread adoption in clinical and personal settings. As a result, the quest for a more convenient, accurate, and non-invasive approach to ketone measurement has fueled innovation in health technology, and AUSMED Global has performed groundbreaking work in breath ketone sensing. Its non-invasive photonic sensing technology represents a significant leap forward, addressing these longstanding challenges and offering a promising path toward more accessible and precise health monitoring.
In the ever-evolving landscape of health technology, AUSMED Global (AUSMED), founded in late 2017 and headquartered in the Hong Kong Science Park, has emerged as a leader in breath ketone sensing technologies, setting new standards in affordable devices and solutions for home and point-of-care use. “Our technology utilizes non- invasive photonic sensing, measuring breath ketones as acetone while also providing a single-use testing kit suitable for both clinical and home use, thus minimizing contamination risk", says Christine Yip, CEO and Founder of AUSMED Global. This innovation is a response to global challenges related to diabetes, overweight, and obesity. KetoMetrics is AUSMED Global’s groundbreaking innovation in breath ketone analysis.
It is a truly non-invasive handheld breath ketone analyzer known for its exceptional accuracy and selectivity. Unlike conventional metal oxide-based breath ketone meters, KetoMetrics is mostly unaffected by other volatile organic compound gases, ensuring precise measurements.
One of its key advantages is its limited contamination risk, thanks to the 'one-test-one-kit' approach. Additionally, KetoMetrics offers users the choice between a washable or one-off breath tube, promoting both personal hygiene and environmental responsibility in different situations. Its ease of use is a standout feature, providing results within minutes, making it highly convenient for managing conditions like diabetic ketoacidosis (DKA) and Euglycemic DKA (EDKA) and monitoring ketosis for weight loss and diet management.
Applications Beyond Imagination
Breath ketone measurement holds immense potential in various applications. For individuals with diabetes, it offers a non-invasive method to monitor ketone levels, ensuring timely intervention in cases of DKA. AUSMED Global’s technology provides a bridge to make monitoring more convenient and accessible.
Beyond medical applications, ketone measurement plays a pivotal role in the booming trend of ketogenic diets and intermittent fasting. Understanding the depth of ketosis is crucial for weight management and exploring potential benefits for conditions like Alzheimer’s and non-alcoholic fatty liver disease.
AUSMED goes beyond hardware innovation. Its smart diet app, complemented by a cloud-based AI expert system for diet management, enables remote patient monitoring and leverages big data analytics for chronic disease risk assessment. This holistic approach is poised to transform public health by comprehensively understanding individual health statuses.
AUSMED’s dedication to excellence is reflected in its efforts to secure regulatory approval in numerous countries
AUSMED’s dedication to excellence is reflected in its efforts to secure regulatory approval in numerous countries. The company has already obtained approval for conducting clinical studies in Hong Kong, marking a significant milestone in its journey. AUSMED’s commitment to innovation has earned it accolades, including the Judges’ Recognition Award of the HKABA NSW Chapter Business Awards 2021 and the Silver Medal from the 2022 Geneva International Exhibition of Inventions for their invention, ‘KetoMetrics – High- Performance Fat Loss Management Solution’.
With expansion plans on the horizon, AUSMED Global will be performing a soft launch in Hong Kong, with plans to expand into Southeast Asia and the Middle East in 2024. Thereafter, it aims to enter the U.S. and the Chinese markets, followed by Europe.
To support this expansion and continue its groundbreaking work, AUSMED Global is preparing for a pre-IPO stage, aiming for a listing on Nasdaq and the Hong Kong Stock Exchange. This move is about the company’s valuation and the potential inclusion of its AI data division, which holds promise for insurance companies and other sectors. In the dynamic realm of health technology, AUSMED Global’s innovative approach to breath ketone sensing stands as a beacon of hope for more accessible and accurate health monitoring. With its expansion plans and commitment to excellence, AUSMED Global is poised to make a lasting impact on global health and wellness.
Christine Yip, Founder & CEO, AUSMED Global
With a rich academic background, Christine Yip holds an MPhil from the University of Hong Kong, where she honed her research acumen. Her dedication to knowledge also led her to Monash University, where she acquired multiple degrees, including MBL, MPA, and GDBA, further enhancing her expertise in business and administration. Her influence reaches far beyond her professional endeavors, as she has actively contributed to various companies, organizations, and NGOs through her directorship. Christine’s expansive research interests encompass non-invasive med-tech innovation, digital health management, smart healthcare technology, wellbeing, human-centered smart campus and smart city initiatives, and the application of green technology in the context of smart cities.
We use cookies to ensure you get the best experience on our website. Read more...
.jpg "Technology in Cancer Care: A story of evolving paradigms")
.jpg "Bringing Shop Floor to Manufacturer's palm: Smart Factory Solutions for tomorrow")
